BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee YY, Wu JCY. Management of Patients With Functional Heartburn. Gastroenterology 2018;154:2018-2021.e1. [PMID: 29730025 DOI: 10.1053/j.gastro.2018.04.030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Howden CW, Manuel M, Taylor D, Jariwala-Parikh K, Tkacz J. Estimate of Refractory Reflux Disease in the United States: Economic Burden and Associated Clinical Characteristics. J Clin Gastroenterol 2021;55:842-50. [PMID: 33780218 DOI: 10.1097/MCG.0000000000001518] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wang Y, Ye B, Wang M, Lin L, Jiang L. Esophageal Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index in Identifying Proton Pump Inhibitor-refractory Non-erosive Reflux Disease. J Neurogastroenterol Motil 2021;27:525-32. [PMID: 34642272 DOI: 10.5056/jnm20073] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Wang Y, Ding Y, Lin L, Jiang LQ. Esophagogastric junction contractile integral abnormalities in patients with proton pump inhibitor-refractory symptoms. J Dig Dis 2021;22:529-35. [PMID: 34387020 DOI: 10.1111/1751-2980.13038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Karyampudi A, Nabi Z, Ramchandani M, Darisetty S, Goud R, Chavan R, Kalapala R, Rao GV, Reddy DN. Gastroesophageal reflux after per-oral endoscopic myotomy is frequently asymptomatic, but leads to more severe esophagitis: A case-control study. United European Gastroenterol J 2021;9:63-71. [PMID: 32723068 DOI: 10.1177/2050640620947645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
5 Abdul Kadir NP, Ma ZF, Abdul Hafidz MI, Annamalai C, Jayaraman T, Hamid N, Norhasliza S, Abd Aziz A, Yusof Z, Lee H, Lee YY. Comparing Efficacy and Safety of Empirical vs. Guided Therapy for Non-cardiac Chest Pain: A Pragmatic Randomized Trial. Front Med (Lausanne) 2021;8:605647. [PMID: 33659261 DOI: 10.3389/fmed.2021.605647] [Reference Citation Analysis]
6 Scarpignato C, Hongo M, Wu JCY, Lottrup C, Lazarescu A, Stein E, Hunt RH. Pharmacologic treatment of GERD: Where we are now, and where are we going? Ann N Y Acad Sci 2020;1482:193-212. [PMID: 32935346 DOI: 10.1111/nyas.14473] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bonavina L, Fisichella PM, Gavini S, Lee YY, Tatum RP. Clinical course of gastroesophageal reflux disease and impact of treatment in symptomatic young patients. Ann N Y Acad Sci 2020;1481:117-26. [PMID: 32266986 DOI: 10.1111/nyas.14350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Cassiani RA, Dantas RO. ORAL AND PHARYNGEAL TRANSIT IN FUNCTIONAL HEARTBURN. Arq Gastroenterol 2020;57:150-3. [PMID: 32609156 DOI: 10.1590/S0004-2803.202000000-28] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Wang YJ, Lang XQ, Wu D, He YQ, Lan CH, Xiao X, Wang B, Zou DW, Wu JM, Zhao YB, Dettmar PW, Chen DF, Yang M. Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders. J Neurogastroenterol Motil 2020;26:74-84. [PMID: 31650768 DOI: 10.5056/jnm19032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
10 Sato H, Takahashi K, Mizuno KI, Hashimoto S, Kawata Y, Mizusawa T, Tominaga K, Yokoyama J, Terai S. Overlap in disease concept of functional esophageal disorders and minor esophageal motility disorders. J Gastroenterol Hepatol 2019;34:1940-5. [PMID: 31034660 DOI: 10.1111/jgh.14691] [Reference Citation Analysis]
11 Manning LP, Biesiekierski JR. Use of dietary interventions for functional gastrointestinal disorders. Current Opinion in Pharmacology 2018;43:132-8. [DOI: 10.1016/j.coph.2018.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]